These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32668460)

  • 1. COVID-19 Therapeutics: Making Sense of It All.
    Bakare LS; Allen JM
    AACN Adv Crit Care; 2020 Sep; 31(3):239-249. PubMed ID: 32668460
    [No Abstract]   [Full Text] [Related]  

  • 2. Remdesivir and COVID-19.
    Edwards JK; Cole SR; Adimora AA
    Lancet; 2020 Oct; 396(10256):953. PubMed ID: 33010832
    [No Abstract]   [Full Text] [Related]  

  • 3. Remdesivir and COVID-19.
    Glaus MJ; Von Ruden S
    Lancet; 2020 Oct; 396(10256):952. PubMed ID: 33010831
    [No Abstract]   [Full Text] [Related]  

  • 4. Remdesivir and COVID-19.
    Wang LY; Cui JJ; Ouyang QY; Zhan Y; Guo CX; Yin JY
    Lancet; 2020 Oct; 396(10256):953-954. PubMed ID: 33010833
    [No Abstract]   [Full Text] [Related]  

  • 5. Remdesivir and COVID-19: What are the implications for Africa?
    Green RJ; Mustafa F; Sewlall N; Richards GA
    S Afr Med J; 2020 May; 110(6):12942. PubMed ID: 32880546
    [No Abstract]   [Full Text] [Related]  

  • 6. [Remdesivir for patients with COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516
    [No Abstract]   [Full Text] [Related]  

  • 7. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Remdesivir in COVID-19.
    McCreary EK; Angus DC
    JAMA; 2020 Sep; 324(11):1041-1042. PubMed ID: 32821934
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary administration of remdesivir in the treatment of COVID-19.
    Rasmussen HB; Hansen PR; Taboureau O; Thomsen R; Jürgens G
    AAPS J; 2020 Sep; 22(6):121. PubMed ID: 32944838
    [No Abstract]   [Full Text] [Related]  

  • 10. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    Olalla J
    N Engl J Med; 2020 Sep; 383(10):993-994. PubMed ID: 32649077
    [No Abstract]   [Full Text] [Related]  

  • 11. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    McCaw ZR; Kim DH; Wei LJ
    N Engl J Med; 2020 Sep; 383(10):993. PubMed ID: 32649076
    [No Abstract]   [Full Text] [Related]  

  • 12. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    McMahon JH; Udy A; Peleg AY
    N Engl J Med; 2020 Sep; 383(10):992-993. PubMed ID: 32649075
    [No Abstract]   [Full Text] [Related]  

  • 13. Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    Gillenwater S; Rahaghi F; Hadeh A
    N Engl J Med; 2020 Sep; 383(10):992. PubMed ID: 32649074
    [No Abstract]   [Full Text] [Related]  

  • 14. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
    Beigel JH; Tomashek KM; Dodd LE
    N Engl J Med; 2020 Sep; 383(10):994. PubMed ID: 32649078
    [No Abstract]   [Full Text] [Related]  

  • 15. The 11th Trial of a Cardiovascular Clinical Trialist-Coronavirus-2, Part 3.
    Frishman WH
    Cardiol Rev; 2020; 28(6):273-274. PubMed ID: 33017362
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatments for COVID-19: where are we now?
    Mendes A
    Br J Community Nurs; 2020 Aug; 25(8):412-413. PubMed ID: 32757900
    [No Abstract]   [Full Text] [Related]  

  • 17. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
    Jeevaratnam K
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 19. Does lopinavir really inhibit SARS-CoV-2?
    Cattaneo D; Cattaneo D; Gervasoni C; Corbellino M; Galli M; Riva A; Gervasoni C; Clementi E; Clementi E
    Pharmacol Res; 2020 Aug; 158():104898. PubMed ID: 32438034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential repurposing of Favipiravir in COVID-19 outbreak based on current evidence.
    Khambholja K; Asudani D
    Travel Med Infect Dis; 2020; 35():101710. PubMed ID: 32360327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.